Home » Topics » BioWorld Science

BioWorld Science
RSS

Inflammation, coagulation and endothelial activation markers linked to HIV-associated TTP

July 14, 2022

Heptares Therapeutics divulges new histamine H4 receptor antagonists

July 14, 2022

GLS1 inhibitor with antitumor activity in HCT116 xenograft model

July 14, 2022

Janssen Pharmaceutica identifies new Mcl-1 inhibitors

July 14, 2022

Pfizer synthesizes IL-2 production inhibitors

July 14, 2022

Merck & Co. discloses new DNA polymerase inhibitors

July 14, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

Novel genetic polymorphism associated with macroangiopathy risk

July 14, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Novel genetic loci found for venous thromboembolism

July 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...